Full history for every metric is available with a Kvantra account

Stock profile

Adcock Ingram Holdings Limited (AIP.JO)

Country: South AfricaSector: HealthcareIndustry: Drug Manufacturers - Specialty & GenericExchange: JNB

Delisted · last close 12 Nov 2025

Current price
7,480.00 ZAc0.00%
Last close 12 Nov 2025
Benchmarks

Key financial summary

Financials in ZAR
202020212022202320242025TTM
Total revenueZAR m7,3477,7778,7069,1329,6439,7609,760
Operating profitZAR m1,0761,145
Net profitZAR m676657800898814859859
EPS reportedZAR5.715.71
Operating cashflow per shareZAR2.952.95
Capex per shareZAR2.002.00
FCF per shareZAR0.950.95
Free cash flowZAR m139645
Net debtZAR m-104-104
Book value equityZAR m5,8335,833
Book value per shareZAR38.8138.86
Number of sharesm150.3150.12
DPS (TTM paid)ZAR1.652.80

Financial summary

Financials in ZAR
202020212022202320242025TTM
Value
P/E TTMx8.82-
P/B LTMx1.271.88
P/S LTMx0.761.12
P/FCF LTMx53.1117.03
EV/EBITDA LTMx5.119.99
EV/Sales LTMx0.771.11
Earnings Yield LTM%11.34%7.82%
FCF Yield%1.88%5.87%
Quality
ROE%14.72%15.27%
ROIC%12.98%12.98%
Operating margin%11.03%11.03%
Gross margin%32.99%32.99%
FCF/Sales%1.43%1.43%
Growth and momentum
EPS Growth YoY%+8.56%+8.56%
Sales Growth YoY%+1.22%+1.22%
Net Income Growth YoY%+5.47%+5.47%
FCF Growth%-82.94%-82.94%
Operating Profit Growth%+1.09%+1.09%
Dividend and capital structure
Dividend Yield%5.26%3.74%
Dividend Growth%-37.74%-
Payout Ratio%45.32%45.30%
FCF/Debtx0.572.64
Net Debt/EBITDAx0.090.09
EBIT/Net interestx9.059.05
Net debt/market cap%-1.41%-0.95%
Net debt/Equityx-0.02-0.02
Gross debt/equityx0.040.04

Company overview

Adcock Ingram Holdings Limited, established in 1890 and headquartered in Midrand, South Africa, operates as a global manufacturer, marketer, and distributor of diverse healthcare products. Its international footprint extends across South Africa, the United States, Canada, the United Kingdom, broader Europe, and other international regions. The company offers a comprehensive product portfolio, including over-the-counter (OTC) remedies, prescription medications, consumer health goods, and specialized medical instrumentation and surgical supplies. Its extensive pharmaceutical range covers numerous therapeutic classes, such as women's health, cannabidiol applications, antiretroviral treatments, dermatology, central nervous system disorders, respiratory conditions, ophthalmology, generic medicines, cardiovascular health, pain relief, gastroenterology, energy and immunity support (including colds and flu remedies, vitamins, minerals, and food/nutrition supplements), personal care, feminine hygiene, digestive well-being, allergy management, baby care, and cough solutions. Beyond its general healthcare offerings, Adcock Ingram also manufactures and supplies essential hospital and critical care products, such as intravenous solutions, renal dialysis systems, and blood collection supplies. The company serves both private and public sectors within the healthcare industry.

WebsiteN/A
IndustryDrug Manufacturers - Specialty & Generic
Trades inZAc

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Delisted · last close 12 Nov 2025

Adcock Ingram Holdings Limited (AIP.JO)

AIP.JO · JNB · Healthcare
7,480.00 ZAc0.00%
Benchmarks
Financialsin ZAR
20242025TTM
About

Adcock Ingram Holdings Limited, established in 1890 and headquartered in Midrand, South Africa, operates as a global manufacturer, marketer, and distributor of diverse healthcare products. Its international footprint extends across South Africa, the United States, Canada, the United Kingdom, broader Europe, and other international regions. The company offers a comprehensive product portfolio, including over-the-counter (OTC) remedies, prescription medications, consumer health goods, and specialized medical instrumentation and surgical supplies. Its extensive pharmaceutical range covers numerous therapeutic classes, such as women's health, cannabidiol applications, antiretroviral treatments, dermatology, central nervous system disorders, respiratory conditions, ophthalmology, generic medicines, cardiovascular health, pain relief, gastroenterology, energy and immunity support (including colds and flu remedies, vitamins, minerals, and food/nutrition supplements), personal care, feminine hygiene, digestive well-being, allergy management, baby care, and cough solutions. Beyond its general healthcare offerings, Adcock Ingram also manufactures and supplies essential hospital and critical care products, such as intravenous solutions, renal dialysis systems, and blood collection supplies. The company serves both private and public sectors within the healthcare industry.

IndustryDrug Manufacturers - Specialty & Generic
Trades inZAc

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free